Christine Guthrie, University of California – San Francisco
Peter Sarnow, Stanford University
Supriya Shivakumar, Sigma-Aldrich
Robert Singer, Albert Einstein College of Medicine
Erik Sontheimer, RNA Therapeutics Institute, U Mass Medical School
This year, the sold-out event will feature workshops on Genome Editing with CRISPR/Cas Systems. Since 2013, the CRISPR/Cas system has been used for gene editing and gene regulation in a diverse range of species. It has been theorized that, through CRISPR, we may one day be able to alter the genomes of entire populations of organisms. The sessions will be conducted March 17-19.
The RNA Institute will play host to the symposium, with official sponsorship by Sigma-Aldrich, one of the world’s leading makers of high technology life science products, with operations in more than 40 countries.
About The RNA Institute
The RNA Institute, working in collaboration with global academic and corporate researchers, fosters a fertile, dynamic research environment that promotes the development of RNA tools and technologies to address challenging human health problems. Since its inception in 2009, federal, state and private investments have resulted in a significant expansion of faculty, research staff, labs and instrumentation, generating increased training and employment for graduate students and post-doctoral workers in RNA human health research. A world-class scientific staff; an array of advanced equipment in a mobile; modern lab infrastructure; public-private collaborations; and a dedication to scientific mentorship advance research that demonstrates broad application.